The Food & Drug Administration has been notoriously slow to approve new patents and new indications for drugs. At one point, it required seventeen years for a new patent to be approved, which is why American pharmaceutical companies bought European companies to get their products to market more expeditiously.
There was a reason why it required so long. In 1961, Thalidomide was prescribed for pregnant women. It produced horrifying deformities in babies whose lives were short and painful. Because of the public backlash, the testing for new drugs and new indications became long, complex and cumbersome.
But that was then and this is now. With the threat of COVID-19 destroying our populace and the U.S. economy, under enormous pressure the F&DA has approved the use of Chloroquine Phosphate and Hydroxychloroquine Sulfate for the 2019 Coronavirus pandemic.
Having been a pharmaceutical salesman for many years a long time ago, I never thought the F&DA could or would act so swiftly, but it has. That they have is wonderful.
Prescribed with a Z-Pack, Chloroquine Phosphate and
Hydroxychloroquine Sulfate can be a game-changer in the fight against the ravages of the virus. Doctors in every state except for New York, where it is needed most, can now prescribe these drugs for COVID-19. If you test positive, ask your doctor about it. With Israel providing 100 million free pills to the USA, Chloroquine Phosphate is in bountiful supply. This drug, coupled with a Z-Pack, just might save your life.